Status:
COMPLETED
Alcohol and Cannabis Concentrates Co-Administration
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Institute of Cannabis Research, Colorado State University Pueblo
Colorado State University
Conditions:
Alcohol Use Disorder
Cannabis Use
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The goal of this study is to learn about the effects of combining alcohol with cannabis concentrate products which contain high levels of THC. The main question\[s\] it aims to answer are, 1) How does...
Detailed Description
Individuals who drink alcohol commonly report co-using cannabis, and the increasing availability of new formulations of highly potent cannabis products on the legal market means that alcohol is likely...
Eligibility Criteria
Inclusion
- 21-65 years old,
- Heavy drinkers (for men, \>4 drinks in one occasion, or \>14 drinks per week; for women, \>3 drinks in one occasion, or \>7 drinks per week)
- Regular users of legal-market cannabis (at least 3x/week in past 3 months)
- Have experience using cannabis concentrates within the last year
- Willing to obtain a concentrate product of their choice for use in the study.
Exclusion
- Diagnosed with or seeking treatment for alcohol use disorder (AUD) or other substance use disorder (SUD)
- Pregnant, breastfeeding or trying to become pregnant
- Meet criteria for psychotic, bipolar or major depressive disorder with suicidal ideation, or history of these disorders
- Current use of psychotropic (except anti-depressants) or steroid medications
- Report illicit drug use in past 60-days or fail drug screen (drug screen tests for the presence of amphetamines, benzodiazepines, cocaine, THC, methamphetamine and opioids; only THC is allowed to be present in urine in order to be eligible to participate in the study
- Major medical condition contraindicating alcohol and/or cannabis consumption (e.g., liver disease, heart disease, or being told by a doctor that it is unsafe to consume alcohol or cannabis due to a medical condition)
- Have participated in another research study in the past 8 weeks.
Key Trial Info
Start Date :
December 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT05999344
Start Date
December 16 2021
End Date
August 1 2024
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Colorado State University
Fort Collins, Colorado, United States, 80523